Literature DB >> 25365755

Encephalitis of unclear origin diagnosed by brain biopsy: a diagnostic challenge.

Jeffrey M Gelfand1, Gillian Genrich2, Ari J Green1, Tarik Tihan2, Bruce A C Cree1.   

Abstract

IMPORTANCE: Brain biopsy specimens that exhibit encephalitis without specific histopathologic features pose a diagnostic challenge to neuropathologists and neurologists. Such cases are generally referred to pathologically as encephalitis, not otherwise specified (ENOS). A systematic approach to diagnostic evaluation in such patients is challenging, and currently there is no generally accepted algorithm.
OBJECTIVE: To examine ultimate diagnostic outcomes in patients with ENOS diagnosed by brain biopsy. DESIGN, SETTING, AND PARTICIPANTS: This retrospective case series at the University of California, San Francisco, Medical Center, a tertiary care urban neurosciences center, studied patients with encephalitis diagnosed by brain biopsy from January 1, 1983, through December 31, 2011. EXPOSURES: Brain biopsy. MAIN OUTCOMES AND MEASURES: Clinical and neuropathologic diagnosis.
RESULTS: Among 58 patients who met the inclusion criteria for the study, the original pathologic diagnosis was ENOS in 49 patients (84%). The median age was 40 years (interquartile range, 27-53 years), 35 patients were male, and 13 had known human immunodeficiency virus or AIDS. Median time from onset of symptoms to brain biopsy was 66 days (interquartile range, 18-135 days). For the 29 patients in whom material for pathologic analysis was still available, additional neuropathologic review led to a more specific categorization in 10 (34%). Clinical detail and follow-up information was available for 42 patients, and a specific diagnosis was reached with the help of ancillary testing and/or clinical follow-up in 12 patients. Despite a comprehensive neuropathologic review with additional studies and information, 27 patients still had to be classified in the ENOS category at the end of the study. CONCLUSIONS AND RELEVANCE: ENOS is the most common initial type of encephalitis diagnosed by brain biopsy. In such patients, it may be worth having the biopsy materials reviewed again in a comprehensive fashion by a neuropathologist because additional review led to a more specific categorization in one-third of our cases. Ancillary testing, clinical correlation, and clinical follow-up establish more specific diagnoses in some patients. ENOS still remains a diagnostic challenge after all these efforts in many cases. Current algorithms are of limited value. More advanced methods and better diagnostic algorithms are needed to characterize these patients.

Entities:  

Mesh:

Year:  2015        PMID: 25365755     DOI: 10.1001/jamaneurol.2014.2376

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  7 in total

1.  Enteroviral T-cell encephalitis related to immunosuppressive therapy including rituximab.

Authors:  Nicolas Garzo-Caldas; Elena Ruiz-Sainz; Sara Vila-Bedmar; Sara Llamas-Velasco; Aurelio Hernández-Lain; Juan Ruiz-Morales; Dolores Folgueira-López; Alberto Villarejo-Galende
Journal:  Neurology       Date:  2017-06-23       Impact factor: 9.910

2.  Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.

Authors:  Mika Komori; Andrew Blake; Mark Greenwood; Yen Chih Lin; Peter Kosa; Danish Ghazali; Paige Winokur; Muktha Natrajan; Simone C Wuest; Elena Romm; Anil A Panackal; Peter R Williamson; Tianxia Wu; Bibiana Bielekova
Journal:  Ann Neurol       Date:  2015-04-16       Impact factor: 10.422

3.  A Neurologist's Practical Approach to Cognitive Impairment.

Authors:  Philip W Tipton; Gregory S Day; Neill Graff-Radford
Journal:  Semin Neurol       Date:  2021-11-26       Impact factor: 3.420

Review 4.  Rapidly Progressive Dementia.

Authors:  Gregory S Day
Journal:  Continuum (Minneap Minn)       Date:  2022-06-01

Review 5.  Diagnostic Testing of Neurologic Infections.

Authors:  Prashanth S Ramachandran; Michael R Wilson
Journal:  Neurol Clin       Date:  2018-11       Impact factor: 3.806

6.  Chronic enteroviral meningoencephalitis in a patient on rituximab for the treatment of psoriatic arthritis: A case report and brief literature review.

Authors:  Roberto Tellez; Allison M Lastinger; Jeffery P Hogg
Journal:  IDCases       Date:  2019-05-09

7.  Next-generation sequencing of tissue: A logical extension.

Authors:  Joseph R Berger; Michael R Wilson
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-07-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.